Pharmafile Logo
Pharmafocus logo
Advanced Search

Abbott

Showing 15 posts of 102 posts found.

currency-166422_960_720

India’s NPPA identifies 634 non-compliant drug pricings

February 24, 2017
Medical Communications, Sales and Marketing Abbott, AstraZeneca, Cipla, Dr Reddy's, Dr Reddy’s, nppa

India’s National Pharmaceutical Pricing Authority (NPPA) has revealed that as many as 634 drugs from top pharma firms in the …

News

FDA warns that St. Jude’s heart devices could be hacked

January 11, 2017
Medical Communications, Research and Development Abbott, Muddy waters, St. Jude, medsec

The FDA regulator has publicly announced that there are safety issues with certain of St. Jude’s medical devices, including cardiac …

News
abbottweb_2

Abbott completes $25 billion deal for St. Jude

January 9, 2017
Sales and Marketing Abbott, St. Jude

It has been announced that the Federal Trade Commission has approved Abbott Laboratories acquisition of St. Jude Medical for $25 …

News

Abbott-St. Jude $25 billion deal close to clearance

November 16, 2016
Research and Development, Sales and Marketing Abbott, St. Jude, acquisition

EU antitrust regulators are due to reach a decision on the deal on 23 November that would see Abbott Laboratories …

News
jj_sign_on_wall

J&J in $4.33bn eye surgery unit acquisition

September 19, 2016
Manufacturing and Production, Sales and Marketing Abbott, Johnson & Johnson, acquisition

Johnson & Johnson has agreed to buy Abbott Laboratories’ eye surgery equipment unit in an all-cash deal for £4.33 billion …

News

FDA approves first extended depth of focus lenses for people with cataracts

July 18, 2016
Research and Development, Sales and Marketing Abbott, FDA, cataracts

Abbott has announced that the Tecnis Symfony Intraocular Lenses for the treatment of cataracts has been approved by the US …

News
abbottweb

Abbott to purchase St Jude Medical in $25 billion deal

April 28, 2016
Manufacturing and Production, Research and Development, Sales and Marketing $25, 25 billion, Abbott, Medical device, acquisition, purchase, st jude medical

Abbott (NYSE: ABT) has announced an agreement to purchase device manufacturer, St Jude Medical, in a deal worth $25 billion. …

News
abbottweb

FDA says benefits outweigh risks in Abbott’s heart stent, Absorb

March 16, 2016
Research and Development, Sales and Marketing Abbott, absorb, bioresorbable, coronary artery disease

An independent panel convened by the US Food and Drug Administration (FDA) has unanimously voted that the benefits of Absorb, …

News

Novartis and Abbott start year with strong Q1 sales

April 23, 2015
Sales and Marketing Abbott, Amgen, Cosentyx, GSK, Neupogen, Novartis, Secukinumab, Zarxio, biosimilar, filgrastim, financials

Novartis and Abbott have both posted strong first-quarter results and made bullish predictions about their financial performance in 2015. Novartis …

News
Perrigo image

Mylan in huge $29 billion bid for Perrigo

April 9, 2015
Abbott, Mylan, OTC, Perrigo, Shire

Mylan has offered to pay the over-the-counter (OTC) drug specialist Perrigo $28 billion to acquire its business. The proposed deal …

News
Mylan image

Mylan buys into women’s health

February 3, 2015
Sales and Marketing Abbott, FDA, India, Mylan, famy care, female, women

Mylan is to acquire a number of women’s healthcare companies from Indian-based Famy Care that will build upon its 2008 …

News
GSK image

GSK-Novartis mega-deal signed-off by EC

January 29, 2015
Research and Development, Sales and Marketing Abbott, GSK, Mylan, Novartis, acquisition, etc, merger

The European Commission has approved a GSK-Novartis M&A deal, in which GSK will purchase Novartis’ vaccines unit and Novartis will …

News
Abbott image

Abbott buys Russian firm Veropharm

December 15, 2014
Manufacturing and Production, Sales and Marketing Abbott, Fresenius, cfr pharma, petrovax, sistema, veropharm, zenitco

Abbott has completed its purchase of Russia-based Veropharm in a $305 million deal as it looks to firmly establish itself …

News
Mylan image

Mylan shells out $32.5m to cover tax inversion fines

December 11, 2014
Sales and Marketing AbbVie, Abbott, Mylan, SEC, bresch, coury

Mylan will pay five of its top executives an early $32.5 million to cover penalties from the company’s plans to …

News
Abbvie image

AbbVie financials beat expectations

October 31, 2014
Sales and Marketing AbbVie, Abbott, Creon, Humira, Iopinavir/ritonavir, Kaletra, Q3, Synthroid, levothyroxine, pancrelipase

AbbVie has announced higher-than-expected financial results for the third quarter of 2014, although it continues to rely heavily on blockbuster …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026